Determinants of Asthma Morbidity Among Inner-City Populations (Text Version) Slide presentation from the AHRQ 2008 conference showcasing Agency research and projects. Slide Presentation from the AHRQ 2008 Annual ConferenceOn September 8, 2008, Juan P. Wisnivesky, made this presentation at the 2008 Annual Conference. Select to access the PowerPoint® presentation (708 KB; Plugin Software Help).Slide 1Determinants of Asthma Morbidity Among Inner-City PopulationsJuan P. Wisnivesky, MD, MPHDivisions of General Internal Medicine and Pulmonary, Critical Care,and Sleep MedicineMount Sinai School of Medicine.Slide 2Inner-City AsthmaAsthma is a chronic disease affecting 15 to 17 million Americans.Minority inner-city populations are disproportionately affected by asthma.African Americans and Hispanics have 2 to 3 times greater rates of death due to asthma when compared to whites.New York City has asthma mortality rates 10 times the national average.Slide 3Determinants of Morbidity Among Inner-City AsthmaticsStudy Goal: to evaluate the role of patient, provider, and environmental factors on outcomes of inner-city asthmaticsSlide 4Study OutlineMonth 0-1: Demographics, Asthma regimen, medication beliefs, disease beliefs, communication: Physician Survey: Mount Sinai Hospital Metropolitan Hospital, North General Hospital, Local health centers, Rutgers UniversityBaseline Survey: Mount Sinai Hospital, Rutgers University/Pulmonary function tests, Blood for IgE, serum, DNA Chart reviewMonth 1-3: Electronic measure of adherence* First telephone follow-up.Month 3-12: Adherence, Asthma control, Resource utilization, Quality of life. Second telephone follow-up.Month 12: Third telephone follow-up.Note: *Covers month 1 through 12.Slide 5Potential Determinants of Asthma Morbidity in Inner-City PopulationsThe diagram shows both the internal and external factors in play with a patient's Asthma.Internal Influences: Clinical Factors: GeneticsAsthma historySensitizationSmokingBehavioral Processes: Adherence to controller medsAdherenceSelf-regulation of medsSelf-monitoringTrigger avoidanceCognitive/Emotional Processes Self regulation beliefsKnowledgeSelf efficacyDepression/anxietySociodemographics: Age, sex, race, ethnicityLanguage, culture, education, and income.External Influences: Environmental Factors: Housing conditionsPassive smokingAeroallergensAir pollutionPhysician Factors: KnowledgeAttitudesCommunicationLanguageSystem Factors: Access to carePt education capacityGatekeepingInsuranceTransportationOutcomes: SymptomsQuality of lifeAirway functionResource utilizationSlide 6Characteristics of Study Population (N=326)CharacteristicValueAge (yrs), mean�SD48�13Female (%)83Race/Ethnicity (%) Hispanic56 African-American28 White12 Others4Insurance (%) Medicaid62 Medicare18 Commercial17 Uninsured3Income <$15,000/yr (%)62Asthma History Age Onset (yrs), mean±SD26±15 ED visit last year (%)52 Hospitalized last year (%)23Controller Medication (%)25Comorbid Conditions (%) Eczema19 Chronic sinusitis23 Diabetes25 Hypertension46Environmental Exposure (%) Second hand smoking25 Cat23 Cockroach44 Dampness/Mold51 Rodents40Slide 7Disease Beliefs and Asthma Self-ManagementSelf-management is critical for long-term asthma control"Do you think you have asthma all of the time or only when you are having symptoms?"Responses: I have it all of the time.Most of the time.Some of the time.Only when I am having symptoms.53% of patients were classified as having the no symptoms-no asthma, acute episodic disease belief.Note: Halm EA, et al. No Symptoms, No Asthma. The Acute Episodic Disease Belief Is Associated With Poor Self-Management Among Inner-City Adults With Persistent Asthma. Chest, 2006.Slide 8Associations Between the No Symptoms, No Asthma Belief and Other Key Asthma Beliefs and BehaviorsBeliefs and BehaviorsAcute Belief, %Chronic Belief, %OR (CI)I will not always have asthma3194.49 (1.94—10.42)My lungs are always inflamed/irritated43670.36 (0.20—0.66)Medication beliefsICS use is important when no symptoms56770.38 (0.19—0.74)Medication adherence (ICS)Use it all/most of the time when no symptoms45700.35 (0.19—0.64)Other self-management behaviorsRoutine asthma visits when no symptoms50650.54 (0.30—0.97)Use PFM all/most of the days14300.39 (0.19—0.80)Use PFM to self-adjust medicines15250.53 (0.25—1.09)Slide 9Adherence to Inhaled Corticosteroids (ICS)ICS are the cornerstone of asthma therapy.Adherence to ICS is often suboptimal.Medication Adherence Reporting Scale (MARS).60 patients were given an electronic monitoring device.53% of prescribed days used ICS, 35% of the doses prescribed.Identify key medication beliefs independently associated with adherence with ICS.Slide 10Medication Beliefs Associated with ICS Adherence (MARS)Medication BeliefORP-valueImportant to take when asymptomatic4.2<0.001Confident in ability to use ICS as prescribed2.2<0.001Worry about side effects0.5<0.001Medication regimen hard to follow0.50.04Note: Repeated measures regression adjusted for age, sex, prior intubation, and frequency of oral steroid use.Slide 11The Relationship Between Language Barriers and Outcomes of Inner-city Asthmatics11 million people living in the U.S. have no or limited English-language skills.Limited English proficiency can impair access to quality health care.Adequate patient-provider communication is a key aspect of asthma management.The objective of this analysis was to assess how language barriers affect the outcomes of adult inner-city asthmatics.Slide 12Asthma Control in Relationship to English ProficiencyThe bar graph shows:Asthma Control Scores for 1-month follow-up (P=0.01): Non-Hispanics: approximately, 2.7Hispanics, proficient in English: approximately, 2.8Hispanics, limited proficiency: approximately, 3.3Asthma Control Scores for 3-month follow-up (P<0.0001): Non-Hispanics: approximately, 2.6Hispanics, proficient in English: approximately, 2.8Hispanics, limited proficiency: approximately, 3.6Note: Wisnivesky J, et al. Assessing the Relationship between Language Proficiency and Asthma Morbidity amongst Inner-city Asthmatics. Medical Care, In Press.Slide 13Resource Utilization in Relationship to English ProficiencyThe bar graph shows:Percentage of Outpatient Exacerbations (P=0.004): Non-Hispanics: approximately, 19Hispanics, proficient in English: approximately, 17Hispanics, limited proficiency: approximately, 38Percentage of ED Visits-Hospitalizations (P=0.007): Non-Hispanics: approximately, 18Hispanics, proficient in English: approximately, 21Hispanics, limited proficiency: approximately, 35Slide 14Quality of Life in Relationship to English ProficiencyThe bar graph shows:Quality of Life Score for 1-month follow-up (P=0.002): Non-Hispanics: approximately, 4.8Hispanics, proficient in English: approximately, 4.4Hispanics, limited proficiency: approximately, 4Quality of Life Score for 3-month follow-up (P=0.0001): Non-Hispanics: approximately, 4.8Hispanics, proficient in English: approximately, 4.5Hispanics, limited proficiency: approximately, 3.7Slide 15Medication and Disease Beliefs, Self-Efficacy, and Adherence According to English ProficiencyVariableNon-Hispanics N=141Hispanic, Proficient N=120Hispanics, Limited Proficiency N=57P-valueMedication Beliefs (%) Worry Side Effects ICS4051690.002Worry Addiction to ICS243146<0.0001ICS are Controller Meds8580730.19Disease Beliefs (%) No Symptoms, No Asthma2842470.009Asthma is Chronic Disease7262530.02Self-efficacy (%) Confident Control Asthma8476560.003Confident Use ICS9592790.02Control Over Future Health867649<0.0001Slide 16The Role of Allergic Sensitization on Asthma MorbidityInner-city residents are often exposed to high levels of indoor allergens.Sensitization to cockroach allergen has been linked to increased asthma morbidity in children.Recent data suggest that sensitization to indoor allergens may worsen asthma in elderly patients and pregnant women.Objective of the study was to evaluate the role of sensitization to indoor allergens on asthma control among inner-city asthmatics.Slide 17Prevalence of Sensitization to Indoor Allergens Among Inner-city AsthmaticsThe bar graph shows:Percent Sensitized: Dust Mites: approximately, 43%Cat: approximately, 40%Cockroach: approximately, 55%Mouse: approximately, 20%Molds: approximately, 15%Note: Wisnivesky J, et al. Association between indoor allergen sensitization and asthma morbidity in inner-city asthmatics. JACI, 2007.Slide 18Asthma Control According to Sensitization StatusThe line graphs show:Asthma Control Scores for Cockroach Sensitization (p>0.4): Sensitized: Month 0: approximately, 3.3Month 1: approximately, 2.8Month 3: approximately, 3.2Not Sensitized: Month 0: approximately, 3.1Month 1: approximately, 3.0Month 3: approximately, 3.4Asthma Control Scores for Mouse Sensitization (p>0.2): Sensitized: Month 0: approximately, 3.4Month 1: approximately, 3.3Month 3: approximately, 3.6Not Sensitized: Month 0: approximately, 3.2Month 1: approximately, 3.0Month 3: approximately, 3.2Asthma Control Scores for Cat Sensitization (p>0.15): Sensitized: Month 0: approximately, 3.1Month 1: approximately, 3.1Month 3: approximately, 3.1Not Sensitized: Month 0: approximately, 3.1Month 1: approximately, 2.8Month 3: approximately, 2.9Asthma Control Scores for Mold Sensitization (p>0.6): Sensitized: Month 0: approximately, 3.3Month 1: approximately, 3.0Month 3: approxiamately, 3.3Not Sensitized: Month 0: approximately, 3.1Month 1: approximately, 2.8Month 3: approximately, 3.1Slide 19Resource Utilization According to Sensitization StatusThe bar graphs show:Percentage of Cockroach Sensitization: Steroid Use: Sensitized: approximately, 26%Not Sensitized: approximately, 24%ED Visit: Sensitized: approximately, 19%Not Sensitized: approximately, 18%Percentage of Mouse Sensitization Steroid Use: Sensitized: approximately, 18%Not Sensitized: approximately, 25%ED Visit: Sensitized: approximately, 22%Not Sensitized: approximately, 18%Percentage of Cat Sensitization (**P=0.06) Steroid Use: Sensitized: approximately, 20%Not Sensitized: approximately, 28%ED Visit: Sensitized: approximately, 11%Not Sensitized: approximately, 21%Percentage of Mold Sensitization Steroid Use: Sensitized: approximately, 15%Not Sensitized: approximately, 20%ED Visit: Sensitized: approximately, 15%Not Sensitized: approximately, 20%Slide 20Barriers to Adherence to Asthma Management Guidelines among Primary Care ProvidersKnowledge Lack of Familiarity VolumeTimeAccessibilityLack of Awareness VolumeTimeAccessibilityAttitudes Lack of Outcome ExpectancyLack of Self-efficacyLack of Motivation/InertiaLack of Agreement Specific itemsGuidelines in generalBehavior External Barriers Patient factorsGuideline factorsEnvironmental factorsNote: Adapted from Cabana MD, et al. Why don't physicians follow clinical practice guidelines? a framework for improvement. JAMA 1999.Slide 21Primary Care Provider Adherence to National Heart, Lung and Blood Institute (NHLBI) Asthma Guideline RecommendationsThe bar graph shows:Provider Adherence (%) ICS: approximately, 65%Peak Flow Monitoring: approximately, 37%Action Plan: approximately, 8%Allergy Testing: approximately, 10%Influenza Vaccination: approximately, 72%Slide 22Multivariate Predictors of Adherence to the NHLBI Guideline ComponentsBarrierICS UsePF MonitoringORP-valueORP-valueFamiliarity1.40.341.10.75Expect Patient Adherence1.20.873.30.03Self-Efficacy2.80.032.30.05Insufficient Timer0.430.070.680.25Slide 23Multivariate Predictors of Adherence to the NHLBI Guideline ComponentsBarrierAction PlanAll TestingVaccinationORP-valueORP-valueORP-valueFamiliarity1.80.315.50.022.00.05Expect Patient Adherence1.00.99--3.50.01Self-Efficacy4.90.031.30.463.50.05Insufficient Timer1.30.620.60.461.20.83Slide 24LimitationsMay not be generalizable to other inner-city populations.Used self-reported measures of adherence.Unable to directly observe patient-provider encounters.Used self-reported data on provider adherence to the guidelines.Slide 25ConclusionsOutcomes of inner-city asthmatics remain poor.Problem appears to be multifactorial.Suboptimal disease and medication beliefs are associated with poor asthma self-management.Language barriers may also explain the increased levels of asthma morbidity among inner-city Hispanics.The role of allergic sensitization appears to be more important among children than adults with asthma.Familiarity and adherence to key treatment recommendations remains suboptimal amongst providers who take care of a large number of inner-city asthmatics.Slide 26AcknowledgmentsDepartment of Medicine. Ethan A. Halm, MD, MPH.Thomas McGinn, MD, MPH.Michael Iannuzzi, MD.Diego Ponieman, MD.Stephen Berns, MD.Jessica Lorenzo, MPH.Julian Baez.Jessica Segni.Department of Pediatrics. Hugh Sampson, MD.Michelle Mishoe.Department of Geriatrics Albert Siu, MD, MSPH.Rutgers University. Tamara Musumeci, PhD.Howard Leventhal, PhD.Columbia University. David Evans, PhD.Mayer Kattan, MD.Note: These studies were funded by AHRQ and NYC Department of Health. Current as of February 2009 Internet Citation: Determinants of Asthma Morbidity Among Inner-City Populations (Text Version). February 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/events/conference/2008/Wisnivesky.html